Vedolizumab Induces Remission in Two Cases of Ulcerative Colitis With Upper Gastrointestinal Involvement
DEN Open · 2026-04 · 6 (1)
DOI: 10.1002/deo2.70205 ↗Kurz gefasst
Fachartikel in der Zeitschrift DEN Open, online erschienen am 03.09.2025. Verfasst von Shinya Nakatani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Division of Gastroenterology Showa Medical University School of Medicine Tokyo Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ulcerative colitis (UC) predominantly affects the colon; upper gastrointestinal involvement (UGI) has been reported, but no established treatments exist. We report two cases of UC with concomitant UGI that showed positive responses to vedolizumab therapy. Case 1 involved a 29‐year‐old man who developed continuous inflammation extending from the stomach to the jejunum 1 month after an initial UC diagnosis. Intravenous prednisolone provided clinical remission; however, maintenance therapy with oral azathioprine was unsuccessful. Vedolizumab was initiated. Three months later, esophagogastroduodenoscopy (EGD) and colonoscopy confirmed the resolution of inflammation. Case 2 involved a 19‐year‐old man diagnosed with UGI via endoscopy while being evaluated for nausea and fever during UC treatment. 5‐aminosalicylic acid and prednisolone therapies were ineffective; therefore, vedolizumab was administered. Three months later, EGD confirmed mucosal healing. Both patients have maintained clinical remission for >2 years. To our knowledge, this is the first report of UC with UGI involvement that was successfully treated with vedolizumab. These findings suggest that vedolizumab is effective and safe for UGI treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine Division of Gastroenterology Showa Medical University School of Medicine Tokyo Japan.
- Department of Pathology Showa Medical University School of Medicine Tokyo Japan.
ORCID-Profile: Shinya Nakatani
Zitieren
APA
Nakatani, S., Yamazaki, Y., Higuchi, K., Otoyama, Y., Suzuki, N., Kikuchi, K., Fujiwara, T., Katagiri, A., Ohara, J., & Yoshida, H. (2026). Vedolizumab Induces Remission in Two Cases of Ulcerative Colitis With Upper Gastrointestinal Involvement. DEN Open, 6(1). https://doi.org/10.1002/deo2.70205
Vancouver
Nakatani S, Yamazaki Y, Higuchi K, Otoyama Y, Suzuki N, Kikuchi K, et al. Vedolizumab Induces Remission in Two Cases of Ulcerative Colitis With Upper Gastrointestinal Involvement. DEN Open. 2026;6(1). doi:10.1002/deo2.70205
BibTeX
@article{Nakatani2026,
author = {Nakatani, Shinya and Yamazaki, Yuta and Higuchi, Kensuke and Otoyama, Yumi and Suzuki, Norihiro and Kikuchi, Kazuo and Fujiwara, Takahisa and Katagiri, Atsushi and Ohara, Jyun and Yoshida, Hitoshi},
title = {Vedolizumab Induces Remission in Two Cases of Ulcerative Colitis With Upper Gastrointestinal Involvement},
journal = {DEN Open},
year = {2026},
volume = {6},
number = {1},
doi = {10.1002/deo2.70205}
}
EUVIMED